Semler Scientific, Inc.
SMLR
$28.12
$0.030.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 42.98M | 49.23M | 56.29M | 58.94M | 61.74M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.98M | 49.23M | 56.29M | 58.94M | 61.74M |
| Cost of Revenue | 3.93M | 4.45M | 4.76M | 4.57M | 4.52M |
| Gross Profit | 39.04M | 44.78M | 51.53M | 54.37M | 57.22M |
| SG&A Expenses | 29.07M | 27.20M | 25.81M | 26.88M | 27.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.77M | 36.62M | 35.36M | 36.41M | 37.38M |
| Operating Income | 5.20M | 12.61M | 20.93M | 22.52M | 24.36M |
| Income Before Tax | 44.65M | -34.78M | 47.89M | 18.12M | 18.74M |
| Income Tax Expenses | 7.60M | -4.91M | 6.99M | 2.21M | 2.92M |
| Earnings from Continuing Operations | 37.05 | -29.88 | 40.90 | 15.91 | 15.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.05M | -29.88M | 40.90M | 15.91M | 15.82M |
| EBIT | 5.20M | 12.61M | 20.93M | 22.52M | 24.36M |
| EBITDA | 5.41M | 12.85M | 21.22M | 22.82M | 24.71M |
| EPS Basic | 3.40 | -2.31 | 5.31 | 2.30 | 2.32 |
| Normalized Basic EPS | 4.52 | 0.32 | 3.90 | 1.90 | 2.04 |
| EPS Diluted | 2.43 | -2.61 | 4.92 | 2.04 | 2.03 |
| Normalized Diluted EPS | 3.75 | 0.10 | 3.60 | 1.69 | 1.79 |
| Average Basic Shares Outstanding | 36.40M | 31.62M | 28.92M | 27.69M | 27.36M |
| Average Diluted Shares Outstanding | 39.42M | 33.73M | 31.92M | 31.08M | 31.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |